里德·哈斯廷斯认为科技行业带有某种“大型制药公司”的气质。周一发布的《与卡拉·斯威舍对谈》访谈中，这位奈飞创始人兼前联席首席执行官回应了关于硅谷高管不受欢迎的提问。
Reed Hastings thinks the tech industry has some Big Pharma energy. During an interview with "On with Kara Swisher," released on Monday, the Netflix founder and former co-CEO responded to questions about the unpopularity of Silicon Valley executives. "Well, think of pharma," he said.
“想想制药业，”他说，“制药业为公众所憎恶，但在我看来，它仍在做着惊人且积极的工作。但人们痛恨高昂的药价，所以制药业备受痛恨。”哈斯廷斯还表示，药企开发了“非凡”的产品 —— 如新冠疫苗 —— 却依然招致公众愤怒。“人们因此爱上这些公司了吗？并没有。”
"Pharma is hated by the general public, and to my eyes, is continuing to do amazing and positive work. But people hate the high drug prices, and so pharma is deeply hated." Hastings also said that drug companies have developed "remarkable" products — like the COVID vaccines — but still draw public ire. "Did people fall in love with those companies? They did not."
他还将科技高管比作银行和航空公司老板：权势大、影响深远，却普遍不被喜欢。斯威舍提出该问题之际，好莱坞正在全美影院上映多部揭露科技界丑陋篇章的影片。A24 出品的《你能看见一切》票房大卖 —— 这部纪录片跟踪了前 Theranos 首席执行官伊丽莎白·霍尔姆斯入狱前几周的生活。亚伦·索金的《清算社交网》戏剧化呈现 Meta 内部举报事件。
He also compared tech execs to banking and airline bosses: powerful, consequential, and largely disliked. Swisher raised the question as Hollywood is highlighting some of tech's ugliest chapters in movie theaters across America. A24's "You Can See Everything" has blown up the box office — it's a documentary following former Theranos CEO Elizabeth Holmes in the weeks before she reports to prison. Aaron Sorkin's "The Social Reckoning" dramatizes whistleblowing at Meta.
亚历克斯·吉布尼的《马斯克》追踪埃隆·马斯克政治影响力的崛起。卢卡·瓜达尼诺的《人工》将于圣诞节上映，这是一部关于传记片的传记片，聚焦 OpenAI 首席执行官山姆·奥特曼。
Alex Gibney's "Musk" tracks the rise of Elon Musk's political influence. And Luca Guadagnino's "Artificial," a biopic about a biopic that focuses on OpenAI CEO Sam Altman, is out on Christmas.
哈斯廷斯表示，科技界多年来跌出公众青睐并不罕见。大型行业总会招致怀疑。“这是公众看待商业的自然状态，”他说。不过，身兼 Anthropic 董事会成员的哈斯廷斯称，硅谷公司仍握有一只潜在的“公关下金蛋的鹅”。“我们必须真正治愈一些疾病，”他说，“那会有帮助。”
Hastings said that tech's yearslong tumble out of public favor is not particularly unusual. Large industries always invite skepticism. "That's the natural state of how much of the public thinks about business," he said. Still, Hastings, who sits on Anthropic's board, said that Silicon Valley companies still have one potential PR golden goose. "We've got to actually cure some diseases," he said. "That'll help."